Articles tagged with Esophageal Cancer
A new study from IHME found that chewing tobacco use contributed to an estimated 251,000 deaths globally in 2023, with health loss concentrated in South Asia. Chewing tobacco use was more common among males than females, with significant variations by age and sex.
The UVA Weber Symposium will discuss the latest research and advancements in metastasis, a complex area of cancer research and care. The event will bring together top scientists and physicians to present findings on cancer metastasis, genetics, and treatment considerations.
A NIH-funded research project has generated a comprehensive collection of patient-derived tumor models, covering 25 types of cancer from thousands of donor tissues. These models closely match their parental tumors in terms of genetic alterations and gene expression signatures, enabling researchers to explore tumor evolution and diversity.
A study of over 229,000 obese adults without diabetes found that weight loss drugs, such as semaglutide and tirzepatide, were associated with a 41% decrease in the overall risk of developing obesity-related cancers. GLP-1 RAs also showed larger reductions in certain subgroups, including men and gynaecologic cancers.
A UCF researcher is investigating how probiotics can treat damage from acid reflux disease, which affects one-fourth of Americans and increases the risk for esophageal cancer. Early results show a reduction in Barrett's esophagus and delayed cancer development.
Scientists identified distinctive microbial patterns associated with oesophageal squamous cell carcinoma, a mysterious subtype common in South Africa. The study, published in Communications Medicine, suggests a potential low-cost warning signal for early detection using saliva bacteria analysis.
A rare case of esophageal adenocarcinoma is reported, where the tumor grew outside the esophagus and invaded the thoracic spine, causing spinal cord compression. The patient initially had normal endoscopic findings, highlighting the challenge in detecting rare extraluminal growth patterns.
Researchers found that Barrett's oesophagus is the starting point for all cases of oesophageal adenocarcinoma, even when telltale signs are no longer visible. The study suggests that detecting molecular markers such as TFF3 and REG4 could help identify individuals at risk of developing the disease.
Researchers from UT MD Anderson Cancer Center present studies on single-cell technologies, integrative computational approaches, and experimental therapeutics, highlighting innovations in mRNA vaccines and spatial multi-omics techniques. The studies aim to improve immunotherapy responses and detect treatment-resistant glioma cells.
The study projects that cancer rates in Canada will be high in 2026, with declines seen in some cancers like colorectal and leukemia. However, death rates from pancreatic cancer are increasing.
Researchers developed an AI model to predict Barrett's esophagus recurrence after endoscopic eradication therapy. The tool shows high accuracy in identifying patients at risk and detecting when recurrence is likely to occur.
Researchers developed an AI tool called ONCO-ACS to predict the risk of secondary heart attacks in cancer patients after a heart attack. The tool combines cancer-related factors with standard clinical data to provide reliable information for doctors to balance treatment benefits and harms.
The report shows a notable increase in medication treatments, such as chemotherapy, immunotherapy, and hormone therapy, used before surgery to treat many cancers. Neoadjuvant systemic therapy increased notably for certain cancers, including gynecologic cancers, pancreatic cancer, and rarer abdominal lining cancers.
Researchers developed a technology to map pre-malignant gene mutations and their effects in solid tissues, finding over half of cells contained clonal driver mutations. The study used esophageal tissue samples from six older adults, discovering NOTCH1 and TP53 driver mutations that induced clonal overgrowth and impaired cell development.
A new clinical trial, PAGODA, seeks to minimize treatment interruptions and help patients complete their chemotherapy as planned. The trial will test a structured plan to guide doctors in making small, proactive changes to chemotherapy doses to prevent treatment delays.
Research from Florida Atlantic University strengthens evidence that alcohol consumption increases cancer risk, particularly for breast, colorectal, and liver cancers. Higher intake and specific groups, such as African Americans and those with obesity or diabetes, are found to be more vulnerable to the risks.
The new American Gastroenterological Association guideline emphasizes the need for regular monitoring in many patients with Barrett's esophagus who do not exhibit dysplasia or cancerous changes. The guideline also recommends using high-definition white-light endoscopy in combination with chromoendoscopy to improve detection of Barrett'...
Researchers at Fox Chase Cancer Center demonstrate that pulsed low dose rate (PLDR) chemoradiation therapy can significantly reduce severe side effects, such as painful swallowing problems, while maintaining treatment effectiveness for patients with esophageal and non-small cell lung cancer. The study's key findings show that PLDR brea...
A new guideline from the Canadian Task Force on Preventive Health Care provides a menu of effective options to help people quit smoking, including behavioural and medication options. The guideline aims to address the challenges of nicotine addiction and offers personalized choices for quitting tobacco.
Scientists have developed a monoclonal antibody to combat life-threatening inflammatory diseases like sepsis and ARDS. The antibody shows promise in blocking the immune system's hyperactive response and restoring healthy function without unwanted side effects.
A new technology enables early detection of esophageal cancer by combining optical coherence tomography and optoacoustic imaging to visualize tissue structure and function. This could reduce treatment costs from €140,000 to €10,000 per patient.
Researchers found that decompression with a nasogastric tube is linked to reduced complications in patients after oesophageal cancer surgery. This challenges declining trend of abandoning the tube post-surgery, which was previously thought to be safe.
Early-onset gastrointestinal cancers are rising globally, particularly among younger adults. Colorectal cancer is the most common early-onset GI cancer, accounting for over half of cases, and its incidence is increasing faster than any other type of early-onset cancer.
A study by Baylor College of Medicine reveals that altered genes SOX2 and CDX2 drive Barrett's esophagus formation. The team created organoids from patient tissue, showing that the balance between these genes determines cell identity. This new understanding supports earlier intervention and diagnosis for this potentially deadly cancer.
Researchers developed patient-specific Cancer Chips to model esophageal tumor microenvironments, enabling accurate prediction of chemotherapy responses. The approach can rapidly stratify patients into responders and non-responders, paving the way for personalized medicine.
Researchers developed biomaterial patches loaded with basic fibroblast growth factor to enhance esophageal anastomosis healing. The study showed improved mechanical strength, increased fibroblast proliferation, and enhanced collagen secretion in the experimental group compared to controls.
A new study has found that the capsule sponge test, a less invasive alternative to endoscopies, can accurately stratify patients with Barrett's oesophagus into high, moderate, and low risk categories. This allows for tailored monitoring, reducing unnecessary procedures and improving patient outcomes.
Researchers identified six overexpressed and mutated tumor antigens strongly associated with poor prognosis in esophageal cancer. The study's findings suggest BTN2A1, MICA, and HHLA2 as promising targets for anti-ESCA mRNA vaccines.
A pilot study found that exercising during chemotherapy can increase the number of immune cells fighting cancer, including CD8+ T cells and natural killer cells. The exercise programme improved patients' aerobic fitness, leading to stronger immune responses inside tumours.
Researchers developed a patient-derived organoid library to study chemotherapy resistance in esophageal cancer. Lab-grown mini-tumors showed increased activity in the NRF2 pathway, suggesting potential biomarkers for predicting chemotherapy resistance.
A new study analyzed trends over time in alcohol-linked cancer mortality across the US, finding nearly double the number of alcohol-related cancer deaths between 1990 and 2021. The burden is highest among men over 55, with liver, colorectal, and esophageal cancers seeing significant increases.
Two new predictive algorithms use health data and blood tests to identify high-risk patients, offering improved accuracy in diagnosing cancers. The models identified additional medical conditions associated with increased cancer risk and new symptoms indicative of multiple cancer types.
Researchers from the University of Southampton engineered a new type of super-strong antibody that triggers a stronger response from the immune system compared to naturally produced antibodies. The study confirms that making subtle increases in rigidity stimulates immune activity, creating a powerful immune response against disease.
Excessive alcohol consumption causes severe digestive problems, including liver damage, stomach disorders, and increased cancer risk. Chronic alcohol use can lead to conditions like cirrhosis, pancreatitis, and colorectal cancer.
Researchers at Case Western Reserve University and University Hospitals will test EsoCheck and EsoGuard technologies to detect Barrett's Esophagus, a precursor to esophageal cancer. The goal is to improve detection in an at-risk population with limited endoscopy resources.
A genetic predisposition to type II diabetes mellitus is associated with a reduced risk of esophageal cancer. Metformin use has been shown to decrease the prevalence of esophageal cancer, while insulin and gliclazide have no significant association.
Increased visceral adipose tissue density and decreased skeletal muscle area are predictors of post-esophagectomy pulmonary complications. Decreased skeletal muscle density is associated with poorer overall survival. Routine morphomic analysis can help identify patients at risk and tailor perioperative care.
A team of researchers at Johns Hopkins Medicine has developed a biomarker algorithm that can detect Barrett’s esophagus and esophageal cancer using a noninvasive method. The algorithm uses methylation patterns in genes to identify biomarkers, achieving an AUC of nearly 0.97 in distinguishing healthy tissue from esophageal cancer.
A genetic fault long believed to drive oesophageal cancer development may actually play a protective role early in the disease, according to new research. The study found that defects in CDKN2A were more common in people with Barrett's oesophagus who never progressed to cancer.
A critical study sheds light on the growing global burden of esophageal cancer, with Asia accounting for 75% of new cases and deaths. The research highlights tobacco use and high body mass index (BMI) as leading risk factors, responsible for nearly half of deaths and disability-adjusted life years in men, and a fifth in women.
Achalasia is associated with an increased risk of esophageal squamous cell carcinoma, highlighting the need for close surveillance in high-risk patients. Chronic inflammation and food stasis can lead to malignant transformation, emphasizing the importance of timely intervention.
A phase II clinical trial showed that combining radiation, chemotherapy, and immunotherapy can shrink tumors and allow surgery, resulting in significantly improved outcomes. The study found that patients who underwent surgery had a 82% reduction in risk of death at one year follow-up.
Researchers found that using a multi-step strategy with less-invasive devices can identify patients with Barrett's oesophagus before an endoscopy. This approach is promising for cost-effective screening, which could lead to earlier diagnosis and treatment of oesophageal cancer.
A recent clinical trial found that the Nivolumab and Anlotinib combination therapy significantly reduced tumor size in nearly one-third of patients, while most experienced stability in their condition. The treatment also showed improved survival outcomes compared to historical data, with a manageable safety profile.
Researchers have found that natural killer cells instinctively recognize and attack the XPO1 protein, which drives cancer growth. By targeting this protein, scientists may be able to activate more killer cells to destroy cancer cells. The study suggests that this approach could lead to personalized cancer treatment with less side effects.
Esophageal cancer is a major public health concern in China, with late diagnoses contributing to poor prognosis. Early detection through screening methods like endoscopy and biomarker detection has shown significant outcomes, particularly in high-risk areas.
The study analyzes six major digestive system cancers worldwide and in China, revealing correlations between country HDI and cancer prevalence. Colorectal cancer is the most prevalent, while Asia accounts for 60.5% of new gastrointestinal cancer cases globally.
A clinical trial found that fecal microbiota transplants can boost the effectiveness of immunotherapy in a range of gastrointestinal cancers. The study identified specific bacterial strains associated with better or worse responses, and showed promise for improving treatment outcomes.
A distinct TNF-α signaling program has been identified as a key driver of epithelial cancer development, contributing to cell proliferation and invasion. The researchers found that this program is active in both normal tissues and tumors, but its level of activity correlates with tumor aggressiveness.
A novel inhibitor HVH-2930 targeting heat shock protein 90 (HSP90) demonstrates efficacy against drug-resistant breast cancer cells. It selectively downregulates HER2 signaling, crucial for breast cancer progression, without triggering the heat shock response.
A robotic device mimics natural esophageal and intestinal movement to aid digestion, helping patients with blockages caused by tumors or stents. The device has the potential to improve quality of life for the aging population.
The American Gastroenterological Association recommends considering endoscopic eradication therapy for patients with low-grade dysplasia after discussing risks and benefits. For patients with high-grade dysplasia, the AGA suggests removing abnormal pre-cancerous cells to reduce esophageal cancer mortality.
Researchers have shed light on the complex communication between cells at the gastro-esophageal junction, revealing specific pathways and cellular composition. The study provides new starting points for understanding, preventing, and treating gastrointestinal diseases.
New findings in The American Journal of Pathology indicate that periostin promotes esophageal squamous cell carcinoma progression by enhancing cancer and stromal cell migration in cancer-associated fibroblasts. Periostin may be a promising therapeutic target for treating ESCC.
A new study from Johns Hopkins Medicine found that circulating tumor DNA levels can accurately assess how gastroesophageal cancers respond to treatment and predict future prognosis. The study tracked minimal residual disease by analyzing ctDNA, showing a correlation between ctDNA clearance and cancer-free survival.
Researchers found Mad2 gene expression levels correlate with chromosomal abnormalities in esophageal squamous cell carcinoma, highlighting potential as a clinical biomarker. The study also revealed the deregulation of the Rb-E2F1 circuit and its impact on histone modifications.
A multidisciplinary team created a new algorithm to provide optimal personalized treatment options for individuals with esophageal cancer. The framework uses various heterogeneous factors that facilitate the progression of the disease and demonstrated high accuracy in controlling esophageal cancer.
A recent study published in Cell Reports reveals that cancer cells can prevent the immune system from attacking them by inhibiting key checkpoints. Researchers found that monotherapy agents targeting these checkpoints may not be effective without an inflammatory trigger, explaining why some immunotherapies work while others fail.
A recent study from Drexel University's College of Nursing and Health Professions aimed to understand the challenges and supports affecting individuals with GI cancer and their caregivers when it comes to maintaining a healthy diet and avoiding malnutrition. The research highlighted the importance of creating dietary interventions that...
A new method has been developed to rapidly identify genes that drive tumor growth in various types of cancers. Organoids were used to test candidate genes, revealing promising targets for precision oncology. The study's findings may lead to the development of targeted therapies for patients with esophageal squamous cancer.